PPIP5K2
Basic information
Region (hg38): 5:103120149-103212799
Previous symbols: [ "HISPPD1", "DFNB100" ]
Links
Phenotypes
GenCC
Source:
- hearing loss, autosomal recessive 100 (Moderate), mode of inheritance: AR
- hearing loss, autosomal recessive 100 (Limited), mode of inheritance: AR
- hearing loss, autosomal recessive (Supportive), mode of inheritance: AR
- hearing loss, autosomal recessive 100 (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Deafness, autosomal recessive 100 | AR | Audiologic/Otolaryngologic | Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development | Audiologic/Otolaryngologic | 29590114 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PPIP5K2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 29 | 36 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 24 | 24 | ||||
Total | 0 | 0 | 30 | 3 | 36 |
Variants in PPIP5K2
This is a list of pathogenic ClinVar variants found in the PPIP5K2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-103129219-G-C | Benign (May 14, 2021) | |||
5-103133552-T-C | not specified | Uncertain significance (Dec 01, 2022) | ||
5-103133607-A-G | not specified | Uncertain significance (Jul 14, 2024) | ||
5-103136737-C-G | not specified | Uncertain significance (Jun 07, 2023) | ||
5-103136793-C-T | PPIP5K2-related disorder | Benign (Dec 23, 2019) | ||
5-103136856-A-G | Benign (May 22, 2021) | |||
5-103138463-C-G | not specified | Uncertain significance (Oct 27, 2023) | ||
5-103138467-A-C | not specified | Uncertain significance (Jun 21, 2022) | ||
5-103147827-T-A | Benign (May 14, 2021) | |||
5-103147896-G-A | Benign (May 22, 2021) | |||
5-103147973-C-T | Hearing loss, autosomal recessive 100 | Uncertain significance (Oct 19, 2020) | ||
5-103149252-A-T | not specified | Uncertain significance (Dec 13, 2023) | ||
5-103149306-C-G | not specified | Uncertain significance (Oct 04, 2022) | ||
5-103151019-G-C | Benign (May 14, 2021) | |||
5-103151287-A-G | not specified | Uncertain significance (Sep 20, 2023) | ||
5-103151311-T-G | not specified | Uncertain significance (Nov 20, 2023) | ||
5-103151384-T-G | PPIP5K2-related disorder | Benign (Dec 23, 2019) | ||
5-103152479-G-A | Benign (May 22, 2021) | |||
5-103152485-C-T | Benign (May 20, 2021) | |||
5-103152867-T-C | Benign (May 14, 2021) | |||
5-103153807-T-G | Benign (May 14, 2021) | |||
5-103153930-C-G | not specified | Uncertain significance (Dec 01, 2022) | ||
5-103154707-T-G | PPIP5K2-related disorder | Benign (Mar 01, 2022) | ||
5-103154708-C-T | not specified | Uncertain significance (Nov 10, 2024) | ||
5-103154817-A-G | Benign (May 22, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PPIP5K2 | protein_coding | protein_coding | ENST00000321521 | 29 | 92648 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.58e-21 | 0.983 | 125631 | 0 | 117 | 125748 | 0.000465 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.80 | 375 | 647 | 0.579 | 0.0000336 | 8012 |
Missense in Polyphen | 63 | 206.36 | 0.3053 | 2523 | ||
Synonymous | 0.806 | 197 | 212 | 0.930 | 0.0000105 | 2281 |
Loss of Function | 2.78 | 43 | 67.7 | 0.636 | 0.00000402 | 846 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000974 | 0.000972 |
Ashkenazi Jewish | 0.000217 | 0.000198 |
East Asian | 0.00111 | 0.00109 |
Finnish | 0.0000464 | 0.0000462 |
European (Non-Finnish) | 0.000481 | 0.000475 |
Middle Eastern | 0.00111 | 0.00109 |
South Asian | 0.000510 | 0.000457 |
Other | 0.000861 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Bifunctional inositol kinase that acts in concert with the IP6K kinases IP6K1, IP6K2 and IP6K3 to synthesize the diphosphate group-containing inositol pyrophosphates diphosphoinositol pentakisphosphate, PP-InsP5, and bis- diphosphoinositol tetrakisphosphate, (PP)2-InsP4. PP-InsP5 and (PP)2-InsP4, also respectively called InsP7 and InsP8, regulate a variety of cellular processes, including apoptosis, vesicle trafficking, cytoskeletal dynamics, exocytosis, insulin signaling and neutrophil activation. Phosphorylates inositol hexakisphosphate (InsP6) at positions 1 or 3 to produce PP-InsP5 which is in turn phosphorylated by IP6Ks to produce (PP)2-InsP4. Alternatively, phosphorylates at position 1 or 3 PP-InsP5, produced by IP6Ks from InsP6, to produce (PP)2-InsP4. {ECO:0000269|PubMed:17690096, ECO:0000269|PubMed:17702752}.;
- Pathway
- Phosphatidylinositol signaling system - Homo sapiens (human);inositol pyrophosphates biosynthesis;Metabolism;superpathway of inositol phosphate compounds;Synthesis of pyrophosphates in the cytosol;Inositol phosphate metabolism
(Consensus)
Recessive Scores
- pRec
- 0.114
Intolerance Scores
- loftool
- 0.918
- rvis_EVS
- -0.19
- rvis_percentile_EVS
- 39.24
Haploinsufficiency Scores
- pHI
- 0.102
- hipred
- Y
- hipred_score
- 0.706
- ghis
- 0.601
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ppip5k2
- Phenotype
- hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- inositol metabolic process;phosphorylation;inositol phosphate biosynthetic process;inositol phosphate metabolic process
- Cellular component
- cytosol
- Molecular function
- inositol-1,3,4,5,6-pentakisphosphate kinase activity;inositol hexakisphosphate kinase activity;inositol heptakisphosphate kinase activity;inositol hexakisphosphate 5-kinase activity;ATP binding;diphosphoinositol-pentakisphosphate kinase activity;inositol hexakisphosphate 1-kinase activity;inositol hexakisphosphate 3-kinase activity;5-diphosphoinositol pentakisphosphate 3-kinase activity